PATENT CLAIM ANALYSIS

Application Number: 15950065
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "212040"]

Abstract:
The present disclosure provides crystalline Compound I and crystalline Compound II, pharmaceutical compositions comprising one of said crystalline compounds suitable for intratympanic administration, and methods for treating otic disorders using the crystalline compounds and the pharmaceutical compositions.

Claim (Index 18):
The aqueous pharmaceutical composition according to  claim 17  wherein said aqueous solution comprises approximately 15% to 18% by weight of poloxamer 407, and wherein said crystalline Compound I is present in approximately 0.1% to 5% w/v.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 91.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12837286', '13928157', '14469408', '12506616', '11731663']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7224703236073219
- 35 USC 102 Novelty (BERT): 0.518565193372424
- Combined Prediction Score: 0.7020798105838322
- Mean Citation Score: 244.283842
- Max Citation Score: 256.07574
- Similarity Product: 164.09863036295056

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test